Ascendis Pharma valuation

ASND · NASDAQ · USD

Compare Ascendis Pharma
$271.19Change from previous close: −0.20%Absolute change: −$0.54

Close · November 17, 2026

Valuation

The P/E ratio is 18.1. The average price target of 21 analysts is $315.20.

Data as of November 17, 2026

Ascendis Pharma compared with similar companies

Ascendis Pharma's P/E (trailing 12 months): 18.1, −53% against the median of a group of 7 similar companies (38.3).

Ascendis Pharma's metrics compared with similar companies
MetricAscendis PharmaMedian25th–75th percentileBand
P/E (trailing 12 months)18.138.319.4 – 64.3Low
Forward P/E22.915.712.9 – 25.0Middle
EV/EBITDA46.515.611.1 – 27.9High
Price/book10.76.624.60 – 10.3High
Price/sales15.08.144.99 – 13.6High
Gross margin91.9%77.3%71.2% – 91.5%High
Operating margin30.9%21.7%-39.5% – 31.6%Middle
Net margin72.9%6.7%-19.9% – 30.2%High
ROE132.2%8.3%-1.5% – 88.3%High
Debt/equity0.300.130.02 – 0.92Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$18.06B
Enterprise value
$17.55B
EV/revenue
14.6

Profitability and growth

ROA
13.0%
ROIC
13.0%
Revenue growth (year over year)
73.0%
Earnings growth (year over year)
-445.2%

Financial health

Total cash
$964.36M
Total debt
$447.8M
Current ratio
2.89
Quick ratio
2.22
Altman Z-Score
9.26
Piotroski F-Score
7.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$315.20
Median price target
$314.79
High price target
$355.02
Low price target
$273.24
Analysts with a price target
21
Consensus
Strong buy
Forward EPS
$12.04
EPS estimate, current year
$15.98

Shares and trading

Beta
0.49
Average volume
733.47K
Shares outstanding
65.6M
Float
65.56M
Institutional ownership
101.0%
Insider ownership
0.9%
Short interest (% of float)
5.4%
Short ratio (days)
4.24